LoginGet started
Picture of Natco Pharma logo

NATCOPHARM — Natco Pharma Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual cashflow statement for Natco Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line8,2475,6875,7962,0228,619
Depreciation
Non-Cash Items-669-458-548-187-618
Unusual Items
Other Non-Cash Items
Changes in Working Capital-1,700-2,054-3,429-2,796-1,148
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities6,6884,1732,9884658,491
Capital Expenditures-4,566-3,586-2,546-2,328-1,463
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-1,5561,9161,5132,275-3,308
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-6,122-1,670-1,033-53-4,771
Financing Cash Flow Items-187372-223-188-142
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-509-2,508-1,857348-3,630
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash66-8560853208